A detailed history of Ameriprise Financial Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 289,364 shares of MRNA stock, worth $19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
289,364
Previous 298,657 3.11%
Holding current value
$19 Million
Previous $31.8 Million 7.97%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $940,544 - $1.55 Million
-9,293 Reduced 3.11%
289,364 $34.4 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $46,014 - $62,222
-539 Reduced 0.18%
298,657 $31.8 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $190,735 - $286,555
2,744 Added 0.93%
299,196 $29.8 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $1.21 Million - $1.58 Million
12,504 Added 4.4%
296,452 $30.6 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $575,791 - $780,015
-4,859 Reduced 1.68%
283,948 $34.5 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $2.97 Million - $4.32 Million
21,924 Added 8.21%
288,807 $44.4 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $5.26 Million - $9.34 Million
44,468 Added 19.99%
266,883 $47.9 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $2.81 Million - $4.62 Million
-23,796 Reduced 9.66%
222,415 $26.3 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $4.3 Million - $6.48 Million
-36,707 Reduced 12.97%
246,211 $35.1 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $3.58 Million - $6.66 Million
-28,324 Reduced 9.1%
282,918 $47.6 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $15.6 Million - $25.4 Million
69,045 Added 28.51%
311,242 $75.4 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $11.4 Million - $24.8 Million
51,284 Added 26.86%
242,197 $93.2 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $1.83 Million - $3.31 Million
-14,067 Reduced 6.86%
190,913 $44.9 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $13.9 Million - $23.6 Million
-126,865 Reduced 38.23%
204,980 $26.9 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $5.24 Million - $13.5 Million
79,756 Added 31.64%
331,845 $34.6 Million
Q3 2020

Nov 16, 2020

SELL
$54.34 - $94.85 $1.82 Million - $3.17 Million
-33,446 Reduced 11.71%
252,089 $17.8 Million
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $546,165 - $1.47 Million
-18,408 Reduced 6.06%
285,535 $18.3 Million
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $278,488 - $494,637
15,663 Added 5.43%
303,943 $9.1 Million
Q4 2019

Feb 14, 2020

SELL
$13.93 - $21.28 $1.63 Million - $2.48 Million
-116,758 Reduced 28.83%
288,280 $5.64 Million
Q3 2019

Nov 14, 2019

BUY
$12.26 - $18.07 $4.5 Million - $6.64 Million
367,198 Added 970.4%
405,038 $6.44 Million
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $518,408 - $1.07 Million
37,840 New
37,840 $555,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.